| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
Department of Radiology, Duke University Medical Center, Box 3808, Durham, NC
27710.
2
Department of Radiology, Massachusetts General Hospital, 55 Fruit St., Boston
MA 02114.
OBJECTIVE. The purpose of this study was to compare permeability measurements in high-grade and low-grade glial neoplasms using a T2*-weighted method. Our hypothesis was that permeability measurements using a T2*-weighted technique would show permeability in high-grade neoplasms to be higher than that in low-grade neoplasms.
MATERIALS AND METHODS. Twelve patients with biopsy-proven high-grade neoplasms and 10 patients with biopsy-proven low-grade neoplasms underwent dynamic susceptibility contrast MR perfusion imaging (TR/TE, 1500/80) after bolus infusion of 0.2 mmol/kg of MR contrast material. Color-coded permeability-weighted maps were created using a model that weights relative contributions to signal intensity from intravascular T2* effects and extravascular T1 effects from blood-brain barrier permeability. Two measures of permeability were performed: mean value of highest permeability found on three images through the tumor (mean regional value) and highest value found at any region of interest in the tumor (single area of maximum permeability). Depending on the normality of the data sets, we used the Wilcoxon's rank sum test or the two-tailed Student's t test for statistical analysis.
RESULTS. For low-grade tumors, the range was 0.006-0.041, and the median of the mean regional value for each image was 0.017. For high-grade tumors, the range was 0.005-0.092, and the median of the mean regional value was 0.035 (p = 0.025). For low-grade tumors, the range was 0.008-0.045, and the mean of the single area of maximum values was 0.02. For high-grade tumors, the range was 0.007-0.136, and the mean of the single area of maximum values was 0.054 (p = 0.018).
CONCLUSION. Permeability values for high-grade tumors obtained using a T2*-weighted method were significantly greater than those for low-grade tumors and are consistent with previous studies reporting results using T1-weighted methods.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Y. Bang, J. L. Saver, J. R. Alger, S. H. Shah, B. H. Buck, S. Starkman, B. Ovbiagele, D. S. Liebeskind, and for the UCLA MRI Permeability Investigators Patterns and Predictors of Blood-Brain Barrier Permeability Derangements in Acute Ischemic Stroke Stroke, February 1, 2009; 40(2): 454 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jain, S.K. Ellika, L. Scarpace, L.R. Schultz, J.P. Rock, J. Gutierrez, S.C. Patel, J. Ewing, and T. Mikkelsen Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 694 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lu, E. Pollack, R. Young, J.S. Babb, G. Johnson, D. Zagzag, R. Carson, J.H. Jensen, J.A. Helpern, and M. Law Predicting Grade of Cerebral Glioma Using Vascular-Space Occupancy MR Imaging AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.M. Lupo, S. Cha, S.M. Chang, and S.J. Nelson Analysis of Metabolic Indices in Regions of Abnormal Perfusion in Patients with High-Grade Glioma AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1455 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha, J.M. Lupo, M.-H. Chen, K.R. Lamborn, M.W. McDermott, M.S. Berger, S.J. Nelson, and W.P. Dillon Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging AJNR Am. J. Neuroradiol., June 1, 2007; 28(6): 1078 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. McConville, D. Hambardzumyan, J. B. Moody, W. R. Leopold, A. R. Kreger, M. J. Woolliscroft, A. Rehemtulla, B. D. Ross, and E. C. Holland Magnetic Resonance Imaging Determination of Tumor Grade and Early Response to Temozolomide in a Genetically Engineered Mouse Model of Glioma Clin. Cancer Res., May 15, 2007; 13(10): 2897 - 2904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Provenzale Imaging of Angiogenesis: Clinical Techniques and Novel Imaging Methods Am. J. Roentgenol., January 1, 2007; 188(1): 11 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cao, V. Nagesh, D. Hamstra, C. I. Tsien, B. D. Ross, T. L. Chenevert, L. Junck, and T. S. Lawrence The Extent and Severity of Vascular Leakage as Evidence of Tumor Aggressiveness in High-Grade Gliomas. Cancer Res., September 1, 2006; 66(17): 8912 - 8917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Provenzale, S. Mukundan, and D. P. Barboriak Diffusion-weighted and Perfusion MR Imaging for Brain Tumor Characterization and Assessment of Treatment Response. Radiology, June 1, 2006; 239(3): 632 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chen, X. Sun, F. De Keyzer, J. Yu, R. Peeters, W. Coudyzer, V. Vandecaveye, W. Landuyt, H. Bosmans, P. Van Hecke, et al. Liver Tumor Model with Implanted Rhabdomyosarcoma in Rats: MR Imaging, Microangiography, and Histopathologic Analysis Radiology, May 1, 2006; 239(2): 554 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cao, P. C. Sundgren, C. I. Tsien, T. T. Chenevert, and L. Junck Physiologic and Metabolic Magnetic Resonance Imaging in Gliomas J. Clin. Oncol., March 10, 2006; 24(8): 1228 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cha Update on Brain Tumor Imaging: From Anatomy to Physiology AJNR Am. J. Neuroradiol., March 1, 2006; 27(3): 475 - 487. [Full Text] [PDF]
|
|
|
|
|
|
S. Cha, L. Yang, G. Johnson, A. Lai, M.-H. Chen, T. Tihan, M. Wendland, and W.P. Dillon Comparison of Microvascular Permeability Measurements, Ktrans, Determined with Conventional Steady-State T1-Weighted and First-Pass T2*-Weighted MR Imaging Methods in Gliomas and Meningiomas. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 409 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Lev and L. Vedolin Permeability versus Cerebral Blood Volume Measurement in Brain Tumor Evaluation: Comparative Clinical Value and Advice to Authors. AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 418 - 419. [Full Text] [PDF]
|
|
|
|
|
|
T. F. Patankar, H. A. Haroon, S. J. Mills, D. Baleriaux, D. L. Buckley, G. J.M. Parker, and A. Jackson Is Volume Transfer Coefficient (Ktrans) Related to Histologic Grade in Human Gliomas? AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2455 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bulakbasi, M. Kocaoglu, A. Farzaliyev, C. Tayfun, T. Ucoz, and I. Somuncu Assessment of Diagnostic Accuracy of Perfusion MR Imaging in Primary and Metastatic Solitary Malignant Brain Tumors AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2187 - 2199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lupo, S. Cha, S. M. Chang, and S. J. Nelson Dynamic Susceptibility-Weighted Perfusion Imaging of High-Grade Gliomas: Characterization of Spatial Heterogeneity AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. M. Maia Jr, S. M. F. Malheiros, A. J. da Rocha, C. J. da Silva, A. A. Gabbai, F. A. P. Ferraz, and J. N. Stavale MR Cerebral Blood Volume Maps Correlated with Vascular Endothelial Growth Factor Expression and Tumor Grade in Nonenhancing Gliomas AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Brubaker, J. K. Smith, Y. Z. Lee, W. Lin, and M. Castillo Hemodynamic and Permeability Changes in Posterior Reversible Encephalopathy Syndrome Measured by Dynamic Susceptibility Perfusion-Weighted MR Imaging AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 825 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manka, F. Traber, J. Gieseke, H. H. Schild, and C. K. Kuhl Three-dimensional Dynamic Susceptibility-weighted Perfusion MR Imaging at 3.0 T: Feasibility and Contrast Agent Dose Radiology, March 1, 2005; 234(3): 869 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Covarrubias, B. R. Rosen, and M. H. Lev Dynamic Magnetic Resonance Perfusion Imaging of Brain Tumors Oncologist, September 1, 2004; 9(5): 528 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, K. Kazmi, S. Wetzel, E. Wang, C. Iacob, D. Zagzag, J. G. Golfinos, and G. Johnson Dynamic Susceptibility Contrast-Enhanced Perfusion and Conventional MR Imaging Findings for Adult Patients with Cerebral Primitive Neuroectodermal Tumors AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 997 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, S. Yang, J. S. Babb, E. A. Knopp, J. G. Golfinos, D. Zagzag, and G. Johnson Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 746 - 755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, M. Law, D. Zagzag, H. H. Wu, S. Cha, J. G. Golfinos, E. A. Knopp, and G. Johnson Dynamic Contrast-Enhanced Perfusion MR Imaging Measurements of Endothelial Permeability: Differentiation between Atypical and Typical Meningiomas AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1554 - 1559. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
